These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada. Sadatsafavi M, FitzGerald JM, O'Byrne PM, Soliman M, Sriskandarajah N, Vicente C, Golam SM. Allergy Asthma Clin Immunol; 2021 Oct 12; 17(1):108. PubMed ID: 34641954 [Abstract] [Full Text] [Related]
14. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M. Health Technol Assess; 2008 May 17; 12(19):iii-iv, 1-360. PubMed ID: 18485271 [Abstract] [Full Text] [Related]
15. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK. N Engl J Med; 2018 May 17; 378(20):1865-1876. PubMed ID: 29768149 [Abstract] [Full Text] [Related]